Firstkind, a Sky Medical Technology Company, is Delighted to Announce RCN Accreditation of its User Training Programme for the geko™ Device for VTE Prevention

Feb 25, 2016, 07:01 ET from Firstkind Limited

LONDON, February 25, 2016 /PRNewswire/ --

Firstkind Ltd, a Sky Medical Technology Company, is delighted to announce accreditation of its user training programme by the Royal College of Nursing (RCN) Centre for Professional Accreditation.

RCN accreditation is peer reviewed by expert representatives drawn from clinical, management and educational fields of practice, and recognises learning and development initiatives that are up to date, of high quality, contribute to patient safety, promote best practice and support nursing and healthcare delivery.

The RCN accredited user training programme for the geko™ device provides hands-on, competency-based training to front-line hospital staff for VTE prevention. The learning objective of the training programme is to understand who the geko™ device is for, how the geko™ device works (its mechanism of action for VTE prevention) and how to correctly fit the device.

Worn at the knee, the geko™ device delivers gentle electrical impulses to stimulate the common peroneal nerve, activating the calf and foot muscle pumps to increase venous, arterial and microcirculatory blood flow. The increase in lower limb blood flow is similar to that achieved by walking, up to 60%, without the patient having to move or exert energy. NICE guidance (MTG19) supports use of the geko™ device for patients who have a high risk for VTE and for whom pharmacological and other mechanical methods of VTE prophylaxis are impractical or contraindicated.

Bernard Ross, CEO Firstkind says, "We are delighted that the training programme has met the RCN's quality criteria for professional standards. Gaining this prestigious accreditation validates the high standards of customer support we work to provide. RCN accreditation provides an internationally recognised seal of approval to medical professionals and clinical teams when assessing learning initiatives that will provide best use of time."

This programme has been accredited by the RCN Centre for Professional Accreditation until 16/11/2016.

Accreditation applies only to the educational content of the programme and does not apply to any product.

About Firstkind and Sky Medical Technology Ltd 

Sky Medical Technology, the parent of Firstkind Ltd, is a highly innovative UK based medical devices company that has developed a ground-breaking neuromuscular electrostimulation technology platform, OnPulse™. The company develops a range of products tailored to the needs of different medical application areas selling both direct and through strategic partnerships or distributors in each major clinical area. Clinical areas of interest include DVT prevention, reduction of oedema, wound healing, elite sport recovery, and continence. The goal in each clinical area is to improve clinical outcomes and patient care whilst saving health system resources.

The geko™ device has secured National Institute of Clinical Excellence (NICE) guidance recommending its use to the NHS for DVT prevention and has US FDA clearance for USA market entry.

http://www.gekodevices.com 

This programme has been accredited by the RCN Centre for Professional Accreditation until 16/11/2016.

Accreditation applies only to the educational content of the programme and does not apply to any product.

SOURCE Firstkind Limited